Inve India ▾

JSIPL share price & results

JSIPL· Capital Goods· Industrials

Results to
Jun 2026
Ownership as of
Sept 2026
Start an Inve Case

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue191 ₹ crore—Quarterly, as filedQuarter to Jun 2026Revenue from operations as filed. No quarter a year earlier is in the series, so no change is shown.
Operating margin7.2 %—Operating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points. No quarter a year earlier is in the series, so no change is shown.
Net profit8.3 ₹ crore—Quarterly, as filedQuarter to Jun 2026Profit after tax as filed. No quarter a year earlier is in the series, so no change is shown.
Return on equityUnavailable+21.9 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin-1.26 %−3.3 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable+24.3 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Price

₹163.34 −3.91% · −₹6.64

Last close 15 Oct 2026 · NSE · INR

Performance +29.6% YTD

₹140₹160₹180₹200SeptOct

YTD: ₹126 on 23 Sept 2026 → ₹163.34. High ₹195.42 (7 Oct 2026), low ₹126 (23 Sept 2026).

Previous close
₹169.98
Market cap
₹856 Cr
52-week range
₹126 – ₹195.42
Price to earnings (FY ending Mar 2026)
37.22×
Return on equity (FY ending Mar 2026)
26.74%

Your own record

Start an Inve Case for JSIPL

Free account: one company. Everything above stays public.

Write why you follow JSIPL and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.